Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Effectiveness and safety of balloon pulmonary angioplasty in a small cohort of CTEPH patients
Session:
Sessão de Comunicações Orais - Hipertensão Pulmonar e Congénitos
Speaker:
Rafael Santos
Congress:
CPC 2020
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Subtheme:
21.4 Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure - Treatment
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Rafael Santos; Claudia Jorge; Miguel Nobre Menezes; Rui Plácido; Tatiana Guimarães; Nuno Lousada; Inês Aguiar Ricardo; Joana Rigueira; Tiago Graça Rodrigues; Nelson P. Cunha; Afonso Nunes Ferreira; Pedro Silvério António; Sara Couto Pereira; Pedro Morais; Fausto José Pinto; Pedro Canas Da Silva
Abstract
<p><strong>Introduction:</strong> Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially life-threatening disease. Balloon pulmonary angioplasty (BPA) is an emerging procedure to treat CTEPH patients who are not candidates to surgery - pulmonary thromboendarterectomy (PTE) - or still have residual pulmonary hypertension and remain symptomatic after PTE.</p> <p><strong>Objective:</strong> to evaluate the early results of a BPA program at a pulmonary hypertension referral center and its impact on the pulmonary hemodynamics parameters and NT-proBNP value.</p> <p><strong>Methods:</strong> we performed a prospective single center study of patients who were submitted to BPA since May 2018 until November 2019 and in whom after repeated sessions a decrease in mean pulmonary arterial pressure (PAPm) bellow 30 mmHg was achieved. Demographic, clinical, laboratorial (NT-proBNP), pulmonary hemodynamic data (right-sided heart catheterization), procedure characteristics and complications were analyzed. For statistical analysis, the Wilcoxon test was used.</p> <p><strong>Results:</strong> During this period, 8 patients were submitted to BPA and met criteria for complete revascularization. The median age was 73 years (IQ 65-75,5), with just 1 male patient. The median number of sessions was 4 (minimum 2, maximum 7). All of the patients were on specific vasodilator therapy and receiving anticoagulation (5 with warfarin and 3 with a NOAC) and three patients were on oxygen therapy. Half of the patients had a previous history of PTE (the median time between surgery and BPA was 24,5 months).</p> <p>Mild hemoptysis was the only complication - 5 (14%) events in a total of 36 sessions. Short duration noninvasive ventilation with CPAP was performed with resolution. No cases of reperfusion injury were reported.</p> <p>Regarding the pulmonary hemodynamics status, a clear decrease in PAPm was observed, from 40 mmHg (IQ36,5-46,5) before BPA to 26 mmHg (IQ21,25-28,5) after BPA (p= 0,012) and in vascular pulmonary resistance - 5,6 WU (IQ4,42-11,21) before BPA vs 3,45 WU (IQ3,2-4,43) after BPA (p= 0,046). There were no significant changes in cardiac output.</p> <p>It was also found a statistically significant decrease in NT-proBNP – 550 ng/L (IQ 208,5-1801) before BPA vs 313 ng/L (IQ 162,75-845,25) after BPA (p= 0,025).</p> <p><strong>Conclusion:</strong> Although our cohort is small, BPA has proven to be a safe procedure, with a few complications of mild degree and with a significant improvement in pulmonary hemodynamics parameters and NT-proBNP values, which is in agreement with the existing literature.</p> <p> </p>
Slides
Video
Our mission: To reduce the burden of cardiovascular disease
Visit our site